The pharma company reported a consolidated net profit of Rs 37 crore, which was down by Rs 84% year-on-year versus Rs 233.39 crore posted by the company in the year-ago period. However, the profit after tax (PAT) jumped over 38% on a quarter-n-quarter basis. The consolidated revenue for the reporting quarter stood at Rs 1,224 crore, down by 22% YoY excluding PO (purchase order), a growth of 18%.
| Subscribe To Our Free Newsletter |
